From small molecule compounds targeting caspase-1 and Akt-1, compound 13 was selected for virtual screening with molecular modeling, molecular docking and MD simulations, for its effect of hepatic fibrosis. This evidence concerns the gene AKT1 and Hepatic fibrosis.